Scarica l'app Stockscreener
53.59
2.31%
1.21
Dopo l'orario di chiusura:
53.73
0.14
+0.26%
Precedente Chiudi:
$52.38
Aprire:
$53
Volume 24 ore:
2.15M
Relative Volume:
0.69
Capitalizzazione di mercato:
$10.15B
Reddito:
$2.83B
Utile/perdita netta:
$-1.02B
Rapporto P/E:
-9.726
EPS:
-5.51
Flusso di cassa netto:
$194.14M
1 W Prestazione:
-4.30%
1M Prestazione:
+18.85%
6M Prestazione:
+19.30%
1 anno Prestazione:
-22.57%
Intervallo 1D:
$52.50
$53.81
Intervallo di 1 settimana:
$52.11
$56.33
Portata 52W:
$38.81
$72.83
Exact Sciences Corp Stock (EXAS) Company Profile
Nome
Exact Sciences Corp
Settore
Industria
Telefono
608-284-5700
Indirizzo
5505 ENDEAVOR LANE, MADISON, WI
Confronta EXAS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EXAS
Exact Sciences Corp
|
53.59 | 9.92B | 2.83B | -1.02B | 194.14M | -5.51 |
|
TMO
Thermo Fisher Scientific Inc
|
481.10 | 178.47B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
195.27 | 138.15B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
655.51 | 51.27B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
127.62 | 35.93B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
190.20 | 31.74B | 15.70B | 1.24B | 2.01B | 6.91 |
Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-27 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-01-02 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-08-02 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-05-10 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-05-05 | Iniziato | UBS | Neutral |
| 2023-03-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-02-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-10-19 | Downgrade | Craig Hallum | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2021-11-03 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-07-29 | Reiterato | BTIG Research | Buy |
| 2021-07-29 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-29 | Reiterato | Oppenheimer | Outperform |
| 2021-07-29 | Reiterato | Stifel | Buy |
| 2021-06-15 | Iniziato | Raymond James | Strong Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-05-25 | Iniziato | Wells Fargo | Equal Weight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-29 | Downgrade | UBS | Buy → Neutral |
| 2020-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-04-02 | Iniziato | Evercore ISI | Outperform |
| 2020-01-10 | Ripresa | BTIG Research | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Iniziato | Dougherty & Company | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-17 | Reiterato | BofA/Merrill | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-09-26 | Iniziato | Oppenheimer | Outperform |
| 2019-02-26 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-09-05 | Ripresa | The Benchmark Company | Hold |
| 2018-08-13 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-01-29 | Iniziato | Goldman | Neutral |
| 2018-01-08 | Reiterato | The Benchmark Company | Buy |
| 2017-11-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2017-11-01 | Downgrade | BTIG Research | Buy → Neutral |
Mostra tutto
Exact Sciences Corp Borsa (EXAS) Ultime notizie
Exact Sciences Corporation (NASDAQ:EXAS) Sees Large Decline in Short Interest - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 1,707,287 Shares of Exact Sciences Corporation $EXAS - MarketBeat
DLD Asset Management LP Invests $3.40 Million in Exact Sciences Corporation $EXAS - MarketBeat
Q3 EPS Estimates for Exact Sciences Lifted by William Blair - MarketBeat
Nasdaq Moves: Should I set a stop loss on QRHCJuly 2025 PostEarnings & Low Risk High Reward Ideas - خودرو بانک
Woodline Partners LP Increases Stock Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Corporation $EXAS Stock Position Reduced by Zevenbergen Capital Investments LLC - MarketBeat
Aug Sectors: Is Exact Sciences Corporation showing insider buyingChart Signals & Weekly Chart Analysis and Trade Guides - خودرو بانک
Craig Hallum Raises Exact Sciences (NASDAQ:EXAS) Price Target to $85.00 - MarketBeat
Exact Sciences Corporation (NASDAQ:EXAS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
FY2025 EPS Estimates for Exact Sciences Lifted by Analyst - MarketBeat
Exact Sciences CEO on Launch of Multi-Cancer Blood Test - MarketScreener
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term - Yahoo Finance
Energy Moves: Is CARGO Therapeutics Inc. forming bullish engulfing patternsIPO Watch & Weekly Sector Rotation Insights - خودرو بانک
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Sahm
Scientech Research LLC Makes New $915,000 Investment in Exact Sciences Corporation $EXAS - MarketBeat
Belpointe Asset Management LLC Reduces Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
Curi RMB Capital LLC Sells 10,902 Shares of Exact Sciences Corporation $EXAS - MarketBeat
FMR LLC Reduces Stake in Exact Sciences Corp by 30.88% - GuruFocus
Graham Capital Management L.P. Buys New Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs - Nasdaq
Exact Sciences price target raised to $85 from $65 at Craig-Hallum - Yahoo Finance
AQR Capital Management LLC Has $43.65 Million Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Vident Advisory LLC Sells 7,937 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences (NASDAQ:EXAS) Cut to Hold at Zacks Research - MarketBeat
Exact Sciences (EXAS) Is Up 11.2% After Launching Cancerguard Multi-Cancer Blood Test With Quest Diagnostics - simplywall.st
Exact Sciences launches blood test that can detect cancers earlier - Wisconsin State Journal
EFG Asset Management North America Corp. Decreases Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences launches Cancerguard blood test for early cancer detection By Investing.com - Investing.com Australia
Exact Sciences Corporation $EXAS Stock Position Decreased by Northwestern Mutual Wealth Management Co. - MarketBeat
Exact Sciences Launches Cancerguard™, Multi-Cancer Early Detection Blood Test - Nasdaq
Exact Sciences Corporation (NASDAQ:EXAS) Short Interest Update - MarketBeat
Exact Sciences’ Cancerguard MCED test launches for $689 - BioWorld MedTech
Should You Continue to Hold EXAS Stock in Your Portfolio? - Nasdaq
Exact Sciences launches Cancerguard blood test for early cancer detection - Investing.com
Exact Sciences launches Cancerguard multi-cancer blood test at $689 - StreetInsider
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test - FinancialContent
Granahan Investment Management LLC Decreases Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
Edmond DE Rothschild Holding S.A. Boosts Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
Wisconsin InnoExact Sciences' multi-cancer blood test | Curate acquired - The Business Journals
Exact Sciences at Baird Conference: Strategic Growth in Cancer Screening - Investing.com
Transcript : Exact Sciences Corporation Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 10 - MarketScreener
Baird Financial Group Inc. Sells 25,414 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences And 2 Other Stocks Estimated To Be Trading Below Their Fair Value - Yahoo Finance
Aug Ideas: Can Exact Sciences Corporation sustain its profitabilityJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - 뉴스영
Ieq Capital LLC Increases Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Should you wait for a breakout in Exact Sciences CorporationJuly 2025 Summary & Daily Technical Stock Forecast Reports - Newser
Exact Sciences Corporation $EXAS Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
Can Exact Sciences Corporation be the next market leaderPortfolio Update Report & Expert Verified Movement Alerts - خودرو بانک
Exact Sciences, Humana Expand Colorectal Cancer Screening Collaboration - Medical Product Outsourcing
What hedge funds are buying Exact Sciences Corporation2025 Bull vs Bear & Daily Stock Momentum Reports - خودرو بانک
Exact Sciences Corp Azioni (EXAS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):